Discover 926 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 926
Active & Responsive
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
for
Chronic Myeloid Leukemia,
Location: Portland OR, Houston TX, Toronto, New York NY,
Sponsor: Enliven Therapeutics
Sex: All
Age: 18+
Code: NCT05304377
Phase 1, Recruiting
Active & Responsive
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
for
Still´s Disease
Location: Portland OR, Salt Lake City UT
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1+
Code: NCT07203001
Phase 2, Recruiting
Active & Responsive
Adjunctive Cannabidiol for Recovery From Opioid Study
for
Opioid Use Disorder (OUD)
Location: Portland OR, New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18 - 65
Code: NCT06940674
Phase 3, Recruiting
Active & Responsive
TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
for
Alcohol Use Disorder, Opioid Use Disorder
Location: Portland OR
Sponsor: Washington State University
Sex: All
Age: 18+
Code: NCT07171359
Recruiting
Active & Responsive
CAN1012 in Pre-Malignant DCIS and LCIS
for
Ductal Carcinoma in Situ, Lobular Carcinoma in Situ
Location: Portland OR
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT07408856
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Portland OR, San Francisco CA, Palo Alto CA, Duarte CA,
Sponsor: Kelonia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07075185
Phase 1, Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Portland OR, Seattle WA, Boise ID, San Francisco CA,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice
for
Cancer Metastatic
Location: Hillsboro OR
Sponsor: Care Partners
Sex: All
Age: 18 - 70+
Code: NCT04049188
Recruiting
Z1 Hip System: Post-Market Clinical Follow Up Study
for
Hip Osteoarthritis,
Location: Portland OR, Platte City MO, Cleveland OH, Charlotte NC,
Sponsor: Zimmer Biomet
Sex: All
Age: 18+
Code: NCT07104279
Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Portland OR, Eugene OR, Walnut Creek CA, Campbell CA,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
for
Diabetic Macular Edema
Location: Portland OR, Eugene OR, Sacramento CA, Walnut Creek CA,